Basoglu, Ozen K.Ozhan, Mustafa HikmetEkren, Pervin KorkmazAk, GunesTasbakan, Mehmet SezaiSayiner, Abdullah2021-05-032021-05-0320200091-73701550-8080https://hdl.handle.net/11454/70276Objective. To investigate the course of biomarkers on admission and follow-up in order to identify early predictors for poor outcome in COVID-19 patients. Methods. in this study, 132 COVID-19 patients were classified as good outcome (n=62) and poor outcome (n=70) groups. Laboratory parameters were evaluated on admission and within 5-7 days after hospitalization. Results. Baseline levels of neutrophil-lymphocyte ratio, CRP, procalcitonin, ferritin, D-dimer and LDH were higher (p<0.01); lymphocyte count was lower in the poor outcome patients. During follow-up there was a larger decrease in lymphocyte count and more prominent increases in other biomarkers (p<0.001). in ROC analysis, the AUCs strongly indicated the poor outcome on days 5-7 of the hospitalization. Conclusions. This study suggests that the follow-up measurements of the biomarkers better predict the poor outcome in COVID-19 pneumonia.eninfo:eu-repo/semantics/closedAccessCOVID-19biomarkersviral pneumoniaprognosisclinical outcomeArticle506848851WOS:00059994490002133334804N/A